Clik here to view.
Seattle Genetics与武田发布 ADCETRIS® (Brentuximab...
华盛顿州博瑟尔和日本大阪 (美国商业资讯) — Seattle Genetics, Inc. (Nasdaq: SGEN)与武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502)今天宣布，自体干细胞移植(ASCT)后立即接受ADCETRIS (brentuximab...
View ArticleClik here to view.
ガルデルマが美容皮膚科・美容外科用の新規筋弛緩剤の試験を米国で開始
スイス・ローザンヌ （ビジネスワイヤ） — 皮膚科に傾注するグローバルヘルスケア企業のガルデルマは本日、新規筋弛緩剤の第2相臨床試験を米国で開始したと発表しました。試験は、ガルデルマが自社開発したボツリヌストキシン液体製剤の美容皮膚科・美容外科環境における安全性と有効性を検討するもので、ガルデルマの既存の神経毒フランチャイズを充実させることになります。...
View ArticleClik here to view.
EDP Biotech宣布， ColoMarker已获得CE标记，获准用于结肠癌早期检测中的体外辅助诊断，计划在欧洲商业化
田纳西州诺克斯维尔 (美国商业资讯) — EDP Biotech Corporation（以下简称“EDP”或 “公司”）是一家全球性的体外诊断创新公司，采用ELISA技术进行挽救生命的、易用的癌症诊断检测，该公司宣布，其用于结肠癌早期检测的辅助诊断产品ColoMarker®已获得CE标记。这是该独特产品走向商业化的关键步骤，该产品将率先在欧洲经济区(EEA)所属30个成员国上市。 EDP...
View ArticleClik here to view.
PharmaEngine, Nanobiotix Enter Global Pivotal Trial of PEP503 (NBTXR3) in...
TAIPEI, Taiwan PharmaEngine Inc. (TWO: 4162), a biopharmaceutical company developing new cancer treatments, and Nanobiotix S.A. (Euronext: NANO), a clinical-stage nanomedicine company pioneering in...
View ArticleClik here to view.
Manhattan Scientifics’ Unparalleled Cancer Measurement Technology Featured in...
ALBUQUERQUE, N.M. Senior Scientific LLC, a subsidiary of Manhattan Scientifics, Inc. (OTCQB: MHTX), is currently collaborating with The University of Texas MD Anderson Cancer Center (MDACC) to...
View ArticleClik here to view.
Galderma在美国启动新型肌肉松弛剂用于皮肤美容和美容手术的研究
瑞士洛桑 (美国商业资讯) — Galderma是一家专注于皮肤科的全球性医疗保健公司，该公司今天宣布在美国启动一种新型肌肉松弛剂的II期临床试验。该研究调查Galderma内部开发的肉毒素液体制剂用于皮肤美容和美容手术的安全性和有效性，并将添加到现有的Galderma神经毒素业务中。 Galderma总裁兼首席执行官Humberto C....
View ArticleClik here to view.
シアトル・ジェネティクスと武田薬品が移植後ホジキンリンパ腫治療の地固め療法としてのアドセトリス（ブレンツキシマブ・ベドチン）の第3相AETHERA臨床試験...
米ワシントン州ボセル & 大阪 （ビジネスワイヤ） — シアトル・ジェネティクス（Nasdaq:...
View ArticleClik here to view.
Gynesonics Named to FierceMedicalDevices ’2014 Fierce 15′
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has been named by...
View ArticleClik here to view.
PrIME Biologics宣布获得 Xeraya Capital牵头的1600万新元投资
新加坡 (美国商业资讯) — PrIME Biologics Private Limited今天宣布，获得Xeraya Capital Labuan Ltd通过其附属公司Pulau Manukan Ventures Labuan Ltd和JP Asia Prime Capital Pte Ltd的投资。 该投资将使PrIME...
View ArticleClik here to view.
International Medica Foundation Provides a Global Sublicense for the First...
ROCHESTER, Minn. The International Medica Foundation announced today that it has sublicensed to BravoVax Co., Ltd. of China the only rotavirus vaccine (RRV-TV) that has been successfully tested in a...
View ArticleClik here to view.
PrIME BiologicsがXeraya Capital主導による1600万シンガポールドルの株式資金調達を発表
シンガポール （ビジネスワイヤ）– PrIME Biologics Private Limitedは本日、子会社のPulau Manukan Ventures Labuan Ltdを通じたXeraya Capital Labuan Ltdと、JP Asia Prime Capital Pte Ltdからの出資について発表しました。 PrIME...
View ArticleClik here to view.
FDA Approves VELCADE® (bortezomib) for Injection for Previously Untreated...
CAMBRIDGE, Mass. Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA)...
View ArticleClik here to view.
Cytori Therapeutics Invited to Participate in Trade Mission to Asia with U.S....
SAN DIEGO Cytori Therapeutics, Inc. (NASDAQ: CYTX) has been selected to participate in a U.S. trade mission to Japan and South Korea led by the U.S. Secretary of Commerce Penny Pritzker. The...
View ArticleClik here to view.
International Medica Foundation为首款面向新生儿的轮状病毒疫苗提供一项全球性转授权
明尼苏达州罗切斯特 (美国商业资讯) — International Medica Foundation今天宣布， 该基金会已向中国武汉博沃生物科技有限公司(BravoVax Co.,...
View ArticleClik here to view.
Jinchi Biotech’s Giant Salamander Glycopeptides Research Paper Published in...
ZHANGJIAJIE, China Jinchi Biotech Ltd. announced that ‘The Giant Salamander Glycopeptides in Resisting Skin Photo-aging Clinical Research’ has been published in ‘Chinese Medical Cosmetology’...
View ArticleClik here to view.
エリテック、欧州バイオ産業協会より2014年「最も革新的な欧州の中小バイオテク企業賞」を受賞
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、欧州バイオ産業協会（EuropaBio）より2014年の「最も革新的な欧州の中小バイオテク企業賞（Most...
View ArticleClik here to view.
The 1st Meeting of the Series Bridging Biomedical Worlds: “Turning Obstacles...
PARIS Stem cells hold great promise for treating a variety of human diseases and injuries. Basic and translational stem cell research is among the most competitive fields in the life sciences. We...
View ArticleClik here to view.
Spain VHIR Selects Macrogen as the Genomics Service Partner
BARCELONA, Spain & SEOUL, South Korea The Vall d’Hebron Research Institute (VHIR, www.vhir.org) in Barcelona, Spain, and the world-leading Genomics services company Macrogen (www.macrogen.com)...
View ArticleClik here to view.
ACM Global Central Laboratory Names New Laboratory Manager at Shanghai Facility
ROCHESTER, N.Y. ACM Global Central Laboratory, a diagnostic central laboratory delivering high-quality testing services that optimize clinical trial outcomes, today announced the appointment of Peng...
View ArticleClik here to view.
Advanced Biological Laboratories, The University of Hong Kong and The Hong...
LUXEMBOURG & HONG KONG Advanced Biological Laboratories (ABL), S.A, The University of Hong Kong and The Hong Kong Polytechnic University are today launching their collaborative tuberculosis (TB)...
View Article